IT1175508B - Un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina cosi' prodotta - Google Patents
Un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina cosi' prodottaInfo
- Publication number
- IT1175508B IT1175508B IT21436/84A IT2143684A IT1175508B IT 1175508 B IT1175508 B IT 1175508B IT 21436/84 A IT21436/84 A IT 21436/84A IT 2143684 A IT2143684 A IT 2143684A IT 1175508 B IT1175508 B IT 1175508B
- Authority
- IT
- Italy
- Prior art keywords
- protein
- polideoxyribonucleotide
- segment
- procedure
- produce
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 2
- 108090000623 proteins and genes Proteins 0.000 title 2
- 238000000034 method Methods 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 230000001131 transforming effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Crystallography & Structural Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8303626A SE8303626D0 (sv) | 1983-06-23 | 1983-06-23 | A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IT8421436A0 IT8421436A0 (it) | 1984-06-15 |
| IT8421436A1 IT8421436A1 (it) | 1985-12-15 |
| IT1175508B true IT1175508B (it) | 1987-07-01 |
Family
ID=20351747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT21436/84A IT1175508B (it) | 1983-06-23 | 1984-06-15 | Un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina cosi' prodotta |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0130166A1 (it) |
| JP (1) | JPS6019493A (it) |
| GB (1) | GB2142033A (it) |
| IT (1) | IT1175508B (it) |
| SE (1) | SE8303626D0 (it) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
| WO1985000831A1 (en) * | 1983-08-10 | 1985-02-28 | Amgen | Microbial expression of insulin-like growth factor |
| GB8522977D0 (en) * | 1985-09-17 | 1985-10-23 | Fujisawa Pharmaceutical Co | Production of insulin-like growth factor 1 |
| DK108685A (da) * | 1984-03-19 | 1985-09-20 | Fujisawa Pharmaceutical Co | Vaekstfaktor i |
| US4738921A (en) * | 1984-09-27 | 1988-04-19 | Eli Lilly And Company | Derivative of the tryptophan operon for expression of fused gene products |
| GB8507833D0 (en) * | 1985-03-26 | 1985-05-01 | Biogen Nv | Production of human somatomedin c |
| EP0219814B1 (en) * | 1985-10-21 | 1991-09-11 | Fujisawa Pharmaceutical Co., Ltd. | Process for production of isulin-like growth factor i and plasmid for production thereof |
| JPH0817708B2 (ja) * | 1986-10-09 | 1996-02-28 | 藤沢薬品工業株式会社 | Met−インスリン様成長因子Iの発現ベクター |
| JPH03505966A (ja) * | 1988-07-14 | 1991-12-26 | ベイラー カレッジ オブ メディシン | 生物高分子の固相組立及び再構築方法 |
| ATE143696T1 (de) * | 1989-02-28 | 1996-10-15 | Canon Kk | Partiell doppelsträngiges oligonukleotid und verfahren zu seiner bildung |
| JP2682738B2 (ja) * | 1989-06-09 | 1997-11-26 | グロペップ プロプライエタリー リミテッド | 成長ホルモン融合蛋白質 |
| KR920003787B1 (ko) * | 1990-03-05 | 1992-05-14 | 한국과학기술 연구원 | 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법 |
| US5288931A (en) * | 1991-12-06 | 1994-02-22 | Genentech, Inc. | Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation |
| AU3812993A (en) * | 1992-03-24 | 1993-10-21 | Synergen, Inc. | Refolding and purification of insulin-like growth factor I |
| US5663304A (en) * | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
| DE19940750A1 (de) | 1998-08-28 | 2000-06-21 | Febit Ferrarius Biotech Gmbh | Träger für Analytbestimmungsverfahren und Verfahren zur Herstellung des Trägers |
| ATE334197T1 (de) | 1999-02-19 | 2006-08-15 | Febit Biotech Gmbh | Verfahren zur herstellung von polymeren |
| AU2006242129A1 (en) | 2005-05-02 | 2006-11-09 | Genzyme Corporation | Gene therapy for spinal cord disorders |
| PT3520823T (pt) | 2005-05-02 | 2021-09-16 | Genzyme Corp | Terapia genética para distúrbios neurometabólicos |
| AR059089A1 (es) | 2006-01-20 | 2008-03-12 | Genzyme Corp | Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal |
| AR059088A1 (es) * | 2006-01-20 | 2008-03-12 | Genzyme Corp | Administracion intraventricular de una proteina para esclerosis lateral amiotrofica |
| MX361816B (es) | 2006-02-09 | 2018-12-17 | Genzyme Corp | Suministro intraventricular lento. |
| CN101460621B (zh) | 2006-06-07 | 2016-01-27 | 建新公司 | 肌萎缩性侧索硬化和其他脊髓失调症的基因治疗 |
| DK2066791T3 (da) | 2006-10-03 | 2012-10-15 | Genzyme Corp | Genterapi for amyotrofisk lateralsklerose og andre rygmarvssygdomme |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ201918A (en) * | 1981-09-18 | 1987-04-30 | Genentech Inc | N-terminal methionyl analogues of bovine growth hormone |
-
1983
- 1983-06-23 SE SE8303626A patent/SE8303626D0/xx unknown
-
1984
- 1984-06-15 IT IT21436/84A patent/IT1175508B/it active
- 1984-06-20 EP EP84850197A patent/EP0130166A1/en not_active Withdrawn
- 1984-06-22 GB GB08416007A patent/GB2142033A/en not_active Withdrawn
- 1984-06-22 JP JP59129038A patent/JPS6019493A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IT8421436A1 (it) | 1985-12-15 |
| JPS6019493A (ja) | 1985-01-31 |
| IT8421436A0 (it) | 1984-06-15 |
| EP0130166A1 (en) | 1985-01-02 |
| GB2142033A (en) | 1985-01-09 |
| SE8303626D0 (sv) | 1983-06-23 |
| GB8416007D0 (en) | 1984-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8421436A0 (it) | Proteina cosi' prodotta. un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la | |
| DK151985A (da) | Humant fysiologisk aktivt polypeptid | |
| FI861210A7 (fi) | N,n'-dialkylguanidinodipeptider. | |
| IT8619338A0 (it) | Peptide sintetico ad attivita'interleukina 1 umana. | |
| IL89804A0 (en) | Biologically active proteins | |
| IT8522214A0 (it) | Esapeptidi ad attivita' ipotensiva. | |
| DE58908574D1 (de) | Elektrode. | |
| TR25164A (tr) | INTEKTISID ÖZELLIKTE N'-SüBSTITüENTLI-N,N-DIACIL- HIDRAZINLER | |
| FI890611L (fi) | 3'-deamino-4'-deoxi-4'-amino -antracykliner. | |
| IT8722816A0 (it) | Unita' pompante. | |
| DE69015728D1 (de) | Verbindungselektrode. | |
| IT8521468A0 (it) | Procedimento per ottenere interferon leucocitario alfa-2dell'uomo. | |
| ES510078A0 (es) | "perfeccionamientos en pulverizadores ultrasonicos". | |
| EP0129582A4 (en) | BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS FOR ORAL ADMINISTRATION. | |
| NO902791L (no) | Proteinhydrolyse. | |
| IT8819791A0 (it) | Peptidi ad attivita' farmaceutica. | |
| DE68915166D1 (de) | Elektrode. | |
| IT8323607A0 (it) | Peptidi biologicamente attivi. | |
| FI895456A0 (fi) | Rekombinant interleukin 2-hybridproteiner. | |
| DE3481420D1 (de) | Physiologisch aktives proteinmaterial. | |
| DK93683D0 (da) | Biologisk aktive peptider | |
| FI861428A7 (fi) | Rekombinoitu ihmisreniini. | |
| FI894538L (fi) | Bly-aluminium-material. | |
| IT1152126B (it) | Procedimento e dispositivo per consentire ad un automobilista di orientarsi, specialmente in una citta' | |
| IT1188646B (it) | Tripeptide ad attivita' immunostimolante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970628 |